2001-March Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Fri Mar 2 04:18:01 2001
Ending: Sat Mar 31 10:00:13 2001
Messages: 145

• [Pharm-policy] PhRMA's patient assistance program (fwd)   James Love
• [Pharm-policy] TAC Open Letter and Challenge to the IIPI President (fwd)   James Love
• [Pharm-policy] UK position on pharmaceuticals (fwd)   James Love
• [Pharm-policy] WSJ: AIDS Epidemic Puts Drug Firms Treatment vs. Profits (fwd)   Robert Weissman
• [Pharm-policy] Report on court case over South Africa Medicines nAct   James Love
• [Pharm-policy] Report ASEAN workshop on TRIPS and Pharmaceuticals   James Love
• [Pharm-policy] pharma union supports South Africa   Mike Palmedo
• [Pharm-policy] Phila. Inquirer on the Medicine Access Movement   Paul Davis
• [Pharm-policy] March 5, 1st day of the Medicines Act trial   James Love
• [Pharm-policy] Trial postponed - CPT comment (fwd)   James Love
• [Pharm-policy] AFL-CIO on Pharma 301 Submission/S.Africa case   Mike Palmedo
• [Pharm-policy] AFL-CIO challenges PhRMA demands for trade sanctions against South Africa   Robert Naiman
• [Pharm-policy] TAC/COSATU/MSF/Oxfam/CPT press release on South African court case   Toby Kasper
• [Pharm-policy] PhRMA's annual 301 submission   Mike Palmedo
• [Pharm-policy] Reuters: Kenay Will Import Cheap Generic AIDS Drugs   Mike Palmedo
• [Pharm-policy] Effect of lawsuit and demonstrations   James Love
• [Pharm-policy] Feinstein/Feingold introduce new legislation   Mike Palmedo
• [Pharm-policy] WSJ: Price War over AIDS drugs   James Love
• [Pharm-policy] CPT comment on CIPLA March 7 compulsory licensing request to the South Africa Department of Trade and Industry   James Love
• [Pharm-policy] Formatting fixed: CPT comment on CIPLA March 7 compulsory licensing request to the South Africa Department of Trade and Industry   James Love
• [Pharm-policy] PhRMA's annual 301 submission   Susan Finston
• [Pharm-policy] Return on Investments   MFJorge@aol.com
• [Pharm-policy] AP: WHO retracts AIDS Lawsuit Statement   Mike Palmedo
• [Pharm-policy] Phila. Inquirer on Merck   Paul Davis
• [Pharm-policy] NYT: (Cipla vs. Merck in South Africa)   Paul Davis
• [Pharm-policy] Merck Price Cuts Not for Brazil, Others   Mike Palmedo
• [Pharm-policy] Text of Feinstein/Feingold bill (S.463)   Mike Palmedo
• [Pharm-policy] NYT on CIPLA CL request   James Love
• [Pharm-policy] WSJ on CIPLA CL request   love@cptech.org
• [Pharm-policy] [breaking-the-silence] AIDS Drugs & South Africa Lawsuit: Large Protest DC March 12. Ambassador will speak   Paul Davis
• [Pharm-policy] AIDS Drugs in Africa: If Cedes to When   love@cptech.org
• [Pharm-policy] Release: AIDS Activists join SA Ambassador + Others, Demanding Treatment (revised)   Paul Davis
• [Pharm-policy] [breaking-the-silence] AIDS Drugs & South Africa Lawsuit: Large Protest DC March 12. Ambassador will speak   Paul Davis
• [Pharm-policy] MSF's d4T campaign   James Love
• [Pharm-policy] Rachel Swarns: SA to declare AIDS and emergency and issue CL   love@cptech.org
• [Pharm-policy] NYT Editorial on funding treatment   love@cptech.org
• [Pharm-policy] WHO-WTO Secretariat Workshop on Differential Pricing and Financing of Essential Drugs   James Love
• [Pharm-policy] WSJ on CIPLA offer   James Love
• [Pharm-policy] Sunday Times: EMERGENCY!   James Love
• [Pharm-policy] Sunday Times: EMERGENCY!   katie@CritPath.Org
• [Pharm-policy] Administrative request   James Love
• [Pharm-policy] International Red Cross on Drug Prices: "unnacceptable"   Mike Palmedo
• [Pharm-policy] Red Cross Slams Drug Firms Over Pricing Policies   Mike Palmedo
• [Pharm-policy] WP: Zoellick on trade and HIV policy   love@cptech.org
• [Pharm-policy] Guardian: Campus revolt challenges Yale over $40m Aids drug   James Love
• [Pharm-policy] (no subject)   Carolyn Green
• [Pharm-policy] Boston Globe article on Beth Israel seeking deal with drug company   James Love
• [Pharm-policy] SA options regarding compulsory licensing   James Love
• [Pharm-policy] SA case - regarding "emergency"   James Love
• [Pharm-policy] The Double Message: Emergency for others but not at home!   MFJorge@aol.com
• [Pharm-policy] TAC 13 March 2001: Questions & Answers and Letter to President]   Mike Palmedo
• [Pharm-policy] IOC Drums Support for South Africa in Drug Trial   Mike Palmedo
• [Pharm-policy] WPost: AIDS Drug Pricing Policies Protested   Robert Naiman
• [Pharm-policy] Reuters: SA rejects emergency declaration   love@cptech.org
• [Pharm-policy] Pat Sidely on SA rejection of emergency call   love@cptech.org
• [Pharm-policy] Melody Peterson: generic Buspirone approval   love@cptech.org
• [Pharm-policy] BMS gives up some patent rights in South Africa   James Love
• [Pharm-policy] Re: [Ip-health] BMS gives up some patent rights in South Africa   Zackie Achmat
• [Pharm-policy] BMS gives up some patent rights in South Africa   Amy Kapczynski
• [Pharm-policy] BMS press releast on ddI and d4T   love@cptech.org
• [Pharm-policy] BMS gives up some patent rights in SouthAfrica   James Love
• [Pharm-policy] Data on HIV drug development background   James Love
• [Pharm-policy] Merck to offer Romania reduced HIV drug prices   James Love
• [Pharm-policy] ddI and d4T patent info   James Love
• [Pharm-policy] D4T Prices from GPO in Thailand   James Love
• [Pharm-policy] TAC Statement on Bristol-Myers Squibb's Price reductions and patent   James Love
• [Pharm-policy] Participant list for WTO/WHO meeting on differential pricing   James Love
• [Pharm-policy] TAC PRESS RELEASE: BMS CONCEDES PATENTS: MAJOR VICTORY!   James Love
• [Pharm-policy] Washington Post on BMS ddi, d4T decision   love@cptech.org
• [Pharm-policy] NYT on BMS action, also note NIH comment   James Love
• [Pharm-policy] Washington Post on Mbeki rejection of HIV emergency   love@cptech.org
• [Pharm-policy] ddI patents, WSJ story on BMS action   love@cptech.org
• [Pharm-policy] Public Funding   David Garmaise
• [Pharm-policy] EU compulsory license for IMS database   love@cptech.org
• [Pharm-policy] More of EU IMS compulsory license inquiry   love@cptech.org
• [Pharm-policy] BMS patent for ddI in Thailand   James Love
• [Pharm-policy] Health GAP to BMS: Issue a Formal, Voluntary License to All Poor Countries   Robert Weissman
• [Pharm-policy] General question about the Medicines Act Bill   steph
• [Pharm-policy] European MPs back SA's Aids-drug fight   James Love
• [Pharm-policy] Yale researchers on d4t   love@cptech.org
• [Pharm-policy] Aspen Pharmacare   love@cptech.org
• [Pharm-policy] BBC: Bad reporting on Emergency issue   love@cptech.org
• [Pharm-policy] Prescription Games and thank you   alan train
• [Pharm-policy] EP on South Africa   James Love
• [Pharm-policy] NYTimes.com Article: The Scientist's Story   Amy Kapczynski
• [Pharm-policy] BMS costs of developing d4T   James Love
• [Pharm-policy] for Joe DiMasi... on the cost issue   James Love
• [Pharm-policy] Cuban AIDS medication   James Love
• [Pharm-policy] Jim Murray's BEUC talk on access to medicine   James Love
• [Pharm-policy] Getting prices to marginal cost   James Love
• [Pharm-policy] Jamie Love's recent false postings on the listserver   amir_attaran@harvard.edu
• [Pharm-policy] Jamie Love's recent false postings on the listserver   James Love
• [Pharm-policy] Brazil and markets for active ingredients for HIV drugs   James Love
• [Pharm-policy] Brazil and markets for active ingredients for HIV drugs   James Love
• [Pharm-policy] Maxine Waters on SA lawsuit & her bill   Mike Palmedo
• [Pharm-policy] Waters on BMS and Merck price cuts   Mike Palmedo
• [Pharm-policy] Salon on Norway event   love@cptech.org
• [Pharm-policy] Class Action Suit v. Bristol   James Love
• [Pharm-policy] Yale Daily News on patent policy   Mike Palmedo
• [Pharm-policy] proper procedure of IV administration of diazepam   DKRInc@aol.com
• [Pharm-policy] RE: Pharm-policy digest, Vol 1 #312 - 3 msgs   NDAULAIRE@globalhealth.org
• [Pharm-policy] RE: Pharm-policy digest, Vol 1 #312 - 3 msgs   Gonsalves, Gregg
• [Pharm-policy] Lumiere-Action/ Cote d' Ivoire   James Love
• [Pharm-policy] Cipla Meeting with WHO and UNAIDS   James Love
• [Pharm-policy] "Reason" abandoned...   George M. Carter
• [Pharm-policy] AFP: Price cuts have little impact on access to AIDS drugs in Uganda   Mike Palmedo
• [Pharm-policy] Query: Drug registration in a bulk procurement system   Paul Davis
• [Pharm-policy] Bulk Procuremnt Query #2   Paul Davis
• [Pharm-policy] pharmaceutical pricing   A.J. Peticolas
• [Pharm-policy] more about Kolassa book on pharm pricing   A.J. Peticolas
• [Pharm-policy] TRIPS/compulsory licensing -question   Prof. Udo Schuklenk
• [Pharm-policy] Bulk Procuremnt Query #2   msmith@Oxfam.org.uk
• [Pharm-policy] TRIPS/compulsory licensing -question   George M. Carter
• [Pharm-policy] NYT: How to Distribute AIDS Drugs   Paul Davis
• [Pharm-policy] Misinformation from JJackson on AIDS drugs and Africa   Robert Weissman
• [Pharm-policy] Re: [Ip-health] TRIPS/compulsory licensing -question   amir_attaran@harvard.edu
• [Pharm-policy] Re: [Ip-health] TRIPS/compulsory licensing -question   Amy Kapczynski
• [Pharm-policy] RE: [Ip-health] TRIPS/compulsory licensing -question   Kirsten Myhr
• [Pharm-policy] WSJ on Abbott annoucement   James Love
• [Pharm-policy] Abbott press release on its offer   Mike Palmedo
• [Pharm-policy] Comment on Abbott announcement and Norvir and Kaletra   James Love
• [Pharm-policy] NIAID press note on Norvir - March 1996   James Love
• [Pharm-policy] NYT on Abbott, also new Corp to sell d4T and other US government funded inventions at low costs in USA and elsewhere   love@cptech.org
• [Pharm-policy] DJ: Developing Countries Seek United Stand On Health Issues   James Love
• [Pharm-policy] SA seeks changes in law on drug trials   love@cptech.org
• [Pharm-policy] Brazil AIDS Drug Dispute Courtbound   James Love
• [Pharm-policy] Letter to Secretary Thompson regarding government funded inventions   James Love
• [Pharm-policy] UK sides with drugs industry over developing world   Mike Palmedo
• [Pharm-policy] Merck v. Brazil   Mike Palmedo
• [Pharm-policy] UK sides with drugs industry over developing world   gittem01@endeavor.med.nyu.edu
• [Pharm-policy] Cuba poised to enter generic AIDS drug market   Amy Kapczynski
• [Pharm-policy] Indian HIV drug prices   James Love
• [Pharm-policy] A few items on patent disclosures regarding government support   love@cptech.org
• [Pharm-policy] CPT and d4T   Gonsalves, Gregg
• [Pharm-policy] Re: [Ip-health] CPT and d4T   James Love
• [Pharm-policy] RE: [Ip-health] CPT and d4T   Gonsalves, Gregg
• [Pharm-policy] RE: [Ip-health] CPT and d4T   Gonsalves, Gregg
• [Pharm-policy] Africa patents - Nevirapine   James Love
• [Pharm-policy] Glaxo on its Uganda patents on combinations of 3TC and AZT   James Love
• [Pharm-policy] Mozambique debate over HIV drugs   James Love
• [Pharm-policy] Brazilian Resolution on Medicines - Commission on Human Rights   James Love
• [Pharm-policy] do patents matter in Africa?   James Love
• [Pharm-policy] Oxfam letter to Univ. of Minnesota on Ziagen   Mike Palmedo
• [Pharm-policy] Merck Drops Prices in Central America   James Love
• [Pharm-policy] Latest participant list for Hosbjor Norway meeting   James Love

Last message date: Sat Mar 31 10:00:13 2001
Archived on: Sat Mar 31 10:00:14 2001

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...